Regenera Announces Publication of RPh201 Phase 2a Study Data for the Treatment of NAION in the Journal of Neuro-Ophthalmology
May 14, 2019 08:00 ET
|
Regenera Pharma
Publication Highlights Encouraging Evidence of RPh201’s Safety and Efficacy in NAION Patients Data Supportive of Company’s Ongoing Multicenter US-Based Phase 3 Trial NESS-ZIONA, Israel, May 14,...